Pyridine → {4-[(Thiazole-2-carbonyl)-amino]-phenyl}-carbamic acid tert-butyl ester

HRID 219556

Reaktionsgleichung

Reaktionsgleichung von HRID 219556
[Si]([C:5]1[S:6][CH:7]=[CH:8][N:9]=1)(C)(C)C.[C:10](Cl)(Cl)=[O:11].C1(C)C=CC=CC=1.[C:21]([NH:28][C:29]1[CH:34]=[CH:33][C:32]([NH2:35])=[CH:31][CH:30]=1)([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22].N1C=CC=CC=1>C(Cl)Cl>[C:24]([O:23][C:21](=[O:22])[NH:28][C:29]1[CH:30]=[CH:31][C:32]([NH:35][C:10]([C:5]2[S:6][CH:7]=[CH:8][N:9]=2)=[O:11])=[CH:33][CH:34]=1)([CH3:27])([CH3:26])[CH3:25]

Komponenten

7

Edukt 5

HCID 1049PyridineHCID 1140TolueneHCID 6371PhosgeneHCID 5884532-TrimethylsilylthiazoleHCID 688611tert-Butyl (4-aminophenyl)carbamate

Produkt 1

HCID 57936351{4-[(Thiazole-2-carbonyl)-amino]-phenyl}-carbamic acid tert-butyl esterAusbeute 10 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

To a solution of 2-TMS-thiazole (2.25 mL, 14.1 mmol) in DCM (5 mL) at 0° C. was slowly added a solution of phosgene in toluene (20%, 7.45 mL, 14.1 mmol) over 15 Min. After stirring for 2 h at RT, the resulting solution was slowly added via syringe to a solution of N—BOC-1,4-phenylenediamine (4.42 g, 21.2 mmol) and pyridine (2.3 mL, 28.2 mmol) in DCM (100 mL) at 0° C. After stirring for 20 h at RT, the reaction mixture was quenched by addition of sat. NaHCO3 (100 mL), EtOAc (150 mL) was added, and the phases were separated. The aqueous phase was extracted with EtOAc (2×75 mL), and the combined organic extracts were dried over MgSO4 and concentrated in vacuo. Purification by column chromatography (10-50% EtOAc in hexanes) afforded the product as an orange solid (452 mg, 10%). 1H-NMR (400 MHz, DMSO-d6) δ 10.66 (s, 1H), 9.34 (s, 1H), 8.12 (d, J=3.1 Hz, 1H), 8.09 (d, J=3.1 Hz, 1H), 7.72 (d, J=7.0 Hz, 2H), 7.42 (d, J=8.9 Hz, 2H), 1.48 (s, 9H). LC/MS (10-99%) M/Z: M+1 obs=320.3; tR=2.90 min.

Aufarbeitung

  1. stirringAfter stirring for 20 h at RT
  2. customthe reaction mixture was quenched by addition of sat. NaHCO3 (100 mL), EtOAc (150 mL)
  3. additionwas added
  4. customthe phases were separated
  5. extractionThe aqueous phase was extracted with EtOAc (2×75 mL)
  6. dry with materialthe combined organic extracts were dried over MgSO4
  7. concentrationconcentrated in vacuo
  8. customPurification by column chromatography (10-50% EtOAc in hexanes)

Quellen und Nachweise

ORD-Eintrag
ord-60593a2e3fba497ca806f9b6e663c14c
Quelldatensatz
uspto-grants-2012_06
Patentnummer
US08202861B2

Verknüpfte Notizen

Wird geladen…